Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GB Sciences, Inc logo — AI-Powered Drug Discovery of Plant-Inspired Biopharma Produc...

GB Sciences, Inc

AI-Powered Drug Discovery of Plant-Inspired Biopharma Products for the Rx Drug Market

Founded 2001 United States Las Vegas, United States 19 employees Post Ipo Equity Total: $2.02M Biotechnology, Health Care +1

General Information

Company Name GB Sciences, Inc
Founded Year 2001
Location United States Las Vegas, United States +1
Founders / Decision Makers
Team member
Employees 19
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Post Ipo Equity
Social

Get notified when GB Sciences, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GB Sciences, Inc

GB Sciences, Inc. is a plant-inspired research and biopharmaceutical drug development company founded in 2001. Their mission revolves around creating patented formulations of plant-based, optimized therapeutic mixtures to address a variety of medical conditions. With a focus on Biotechnology, Health Care, and Manufacturing, the company is headquartered in the United States. Their most recent investment of $20.00KPost-IPO Equity was made on 13 January 2016. As an investor, these factors demonstrate their commitment to innovation in the biopharmaceutical industry, offering potential for growth and impact.

Taxonomy: biopharmaceutical, drug development, plant-based formulations, therapeutic mixtures, medical conditions, patented formulations, plant science, biomedical research, pharmaceutical industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 13 Jan 2016
Post-IPO Equity •••••• - 05 Jun 2014

FAQ About GB Sciences, Inc

AI-Powered Drug Discovery of Plant-Inspired Biopharma Products for the Rx Drug Market
GB Sciences, Inc was founded in 2001.
GB Sciences, Inc is headquartered in Las Vegas, United States.
GB Sciences, Inc operates in the following industries: Biotechnology, Health Care, Manufacturing.
GB Sciences, Inc has approximately 19 employees.
GB Sciences, Inc has completed 2 funding rounds, raising a total of $2.02M. The latest funding stage is Post Ipo Equity.

We're actively collecting intelligence on GB Sciences, Inc.

Track GB Sciences, Inc to get notified

Don't just browse. Track.

Signal Tracker monitors GB Sciences, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy